Corinne Cather, PhD

Original Research

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

March 23, 2016

Anne N. Thorndike, Eric D. Achtyes, Corinne Cather, et al

Original Research

Predictors of Early Abstinence in Smokers With Schizophrenia

November 30, 2008

Melissa A. Culhane, David A. Schoenfeld, Ruth S. Barr, et al

Original Research

Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis

May 15, 2006

David C. Henderson, Paul M. Copeland, Christina P. Borba, et al

Original Research

Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia

September 15, 2005

A. Eden Evins, Thilo Deckersbach, Corinne Cather, et al

Original Research

Medical Morbidity and Mortality in Schizophrenia: Guidelines for Psychiatrists

February 15, 2005

Donald C. Goff, Corinne Cather, A. Eden Evins, et al

Original Research

Attitudes of Schizophrenia Outpatients Toward Psychiatric Medications: Relationship to Clinical Variables and Insight

October 15, 2004

Oliver Freudenreich, Corinne Cather, A. Eden Evins, et al

Original Research

Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction.

March 1, 2004

A. Eden Evins, Corinne Cather, Nancy A. Rigotti, et al

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

Predictors of Early Abstinence in Smokers With Schizophrenia

Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis

Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia

Medical Morbidity and Mortality in Schizophrenia: Guidelines for Psychiatrists

Attitudes of Schizophrenia Outpatients Toward Psychiatric Medications: Relationship to Clinical Variables and Insight

Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction.

ELSEWHERE:

FOLLOW US:

Corinne Cather, PhD

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

Predictors of Early Abstinence in Smokers With Schizophrenia

Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis

Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia

Medical Morbidity and Mortality in Schizophrenia: Guidelines for Psychiatrists

Attitudes of Schizophrenia Outpatients Toward Psychiatric Medications: Relationship to Clinical Variables and Insight

Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction.

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles